Physician profile
Christopher M Keating
NPI 1346773488
$6,174.88
in general payments reported to CMS, 2019-2025
20 companies · $787 in 2025
The $787 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $160 · 2021: $1,566 · 2022: $1,704 · 2023: $1,356 · 2024: $602 · 2025: $787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,745.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $2,535.49 | 2021-2025 | |
| Treace Medical Concepts, INC. | $819.11 | 2022-2025 | |
| Next Science LLC | $597.64 | 2023-2024 | Xperience, Blastx, Surgx |
| Orthofix Medical, INC. | $383.14 | 2021-2025 | Physio-Stim |
| Paratek Pharmaceuticals, INC. | $262.16 | 2020-2024 | Nuzyra |
| Horizon Therapeutics Plc | $261.50 | 2020-2023 | Krystexxa |
| Kerecis Limited | $198.60 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic, INC. | $176.81 | 2023 | Endurant Iis |
| Alfasigma USA, INC. | $175.29 | 2020-2022 | |
| Smith+Nephew, INC. | $166.41 | 2023-2024 | Bone Anchors With Arthroscopic Delivery System, Q-Fix, Coblation |
| Lifenet Health | $159.60 | 2025 | Theragenesis Wound Matrix, Optium (Tgel & Tput) |
| Advanced Oxygen Therapy INC. | $114.49 | 2022 | |
| Abbott Laboratories | $94.52 | 2023 | Proclaim |
| Amgen INC. | $60.15 | 2024-2025 | Krystexxa |
| Stryker Corporation | $59.44 | 2024-2025 | Na, Reelx, Xbraid |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $32.39 | 2021 | |
| Ossio INC | $24.21 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $20.68 | 2025 | |
| Organogenesis INC. | $20.07 | 2021 | |
| Averitas Pharma INC. | $13.18 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Keating listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.